268 related articles for article (PubMed ID: 31977337)
1. Predicting fetoplacental mosaicism during cfDNA-based NIPT.
Neofytou M
Curr Opin Obstet Gynecol; 2020 Apr; 32(2):152-158. PubMed ID: 31977337
[TBL] [Abstract][Full Text] [Related]
2. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
Samura O; Okamoto A
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
[TBL] [Abstract][Full Text] [Related]
3. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
Brison N; Neofytou M; Dehaspe L; Bayindir B; Van Den Bogaert K; Dardour L; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
Prenat Diagn; 2018 Mar; 38(4):258-266. PubMed ID: 29388226
[TBL] [Abstract][Full Text] [Related]
4. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
[TBL] [Abstract][Full Text] [Related]
6. Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA.
Kwon HJ; Yun S; Joo J; Park D; Do WJ; Lee S; Lee MS
Prenat Diagn; 2023 Dec; 43(13):1581-1592. PubMed ID: 37975672
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal testing.
Lo JO; Cori D F; Norton ME; Caughey AB
Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
[TBL] [Abstract][Full Text] [Related]
8. Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing.
Wan J; Li R; Li F; Yu Q; Wang D; Sun X; Zhang Y; Jing X; Tang X; Chen G; Jiang F; Li F; Fu F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9647-9653. PubMed ID: 35282756
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice.
Wan J; Li R; Zhang Y; Jing X; Yu Q; Li F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
Prenat Diagn; 2018 Oct; 38(11):849-857. PubMed ID: 30078205
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of the causes of NIPS sex chromosome aneuploidy false-positive results.
Lyu Z; Huang C
Mol Genet Genomic Med; 2022 Jul; 10(7):e1963. PubMed ID: 35535634
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of expanded NIPT for chromosomal abnormalities and etiology analysis of cytogenetic discrepancies cases.
Hu Y; Liu W; He G; Xu J; Peng Y; Wang J
J Assist Reprod Genet; 2022 Jan; 39(1):267-279. PubMed ID: 35000096
[TBL] [Abstract][Full Text] [Related]
12. Maternal mosaicism of sex chromosome causes discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing.
Wang L; Meng Q; Tang X; Yin T; Zhang J; Yang S; Wang X; Wu H; Shi Q; Jenkins EC; Zhong N; Gu Y
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):527-31. PubMed ID: 26522104
[TBL] [Abstract][Full Text] [Related]
13. The significance of trisomy 7 mosaicism in noninvasive prenatal screening.
Qi Y; Yang J; Hou Y; Guo F; Peng H; Wang D; Du Q; Yin A
Hum Genomics; 2019 Apr; 13(1):18. PubMed ID: 30971315
[TBL] [Abstract][Full Text] [Related]
14. [Value of non-invasive prenatal testing for rare autosomal trisomies in fetuses].
Xie X; Zhao Q; Hu L; Jiang S; Wang X; Zhang W; Li Z; You Y; Lu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2071-2077. PubMed ID: 38189393
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
17. Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing.
Xue Y; Zhao G; Qiao L; Lu J; Yu B; Wang T
Front Genet; 2020; 11():280. PubMed ID: 32273885
[TBL] [Abstract][Full Text] [Related]
18. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
19. [The significance of rare chromosomal abnormalities and fetoplacental mosaicism in prenatal diagnosis in the non-invasive prenatal testing era].
Tidrenczel Z; P Tardy E; Böjtös I; Sarkadi E; Simon J; Pikó H; Vermes G; Demeter J; Beke A
Orv Hetil; 2021 Jul; 162(29):1156-1165. PubMed ID: 34274918
[TBL] [Abstract][Full Text] [Related]
20. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies.
Grati FR; Bajaj K; Zanatta V; Malvestiti F; Malvestiti B; Marcato L; Grimi B; Maggi F; Simoni G; Gross SJ; Ferreira J
Prenat Diagn; 2017 Oct; 37(10):1017-1027. PubMed ID: 28801976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
